These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10770449

  • 1. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [Abstract] [Full Text] [Related]

  • 2. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.
    Biol Psychiatry; 2003 Oct 15; 54(8):806-17. PubMed ID: 14550680
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    Feighner J, Targum SD, Bennett ME, Roberts DL, Kensler TT, D'Amico MF, Hardy SA.
    J Clin Psychiatry; 1998 May 15; 59(5):246-53. PubMed ID: 9632036
    [Abstract] [Full Text] [Related]

  • 4. Nefazodone treatment of comorbid alcohol dependence and major depression.
    Hernandez-Avila CA, Modesto-Lowe V, Feinn R, Kranzler HR.
    Alcohol Clin Exp Res; 2004 Mar 15; 28(3):433-40. PubMed ID: 15084901
    [Abstract] [Full Text] [Related]

  • 5. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK, Robinson DS, Roberts DL, Schwiderski UE, O'Brien K, Ieni JR.
    J Clin Psychiatry; 1996 Mar 15; 57 Suppl 2():15-8. PubMed ID: 8626358
    [Abstract] [Full Text] [Related]

  • 6. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
    Lespérance F, Frasure-Smith N, Laliberté MA, White M, Lafontaine S, Calderone A, Talajic M, Rouleau JL.
    Can J Psychiatry; 2003 Nov 15; 48(10):695-701. PubMed ID: 14674053
    [Abstract] [Full Text] [Related]

  • 7. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS.
    J Clin Psychiatry; 1996 Nov 15; 57 Suppl 2():53-62. PubMed ID: 8626364
    [Abstract] [Full Text] [Related]

  • 8. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
    Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, Roberts DL, Kensler TT, McQuade RD, Kaplita SB, Archibald DG.
    Int Clin Psychopharmacol; 1999 Jan 15; 14(1):19-28. PubMed ID: 10221638
    [Abstract] [Full Text] [Related]

  • 9. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.
    Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF.
    J Clin Psychiatry; 1995 Mar 15; 56 Suppl 6():30-6. PubMed ID: 7649971
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.
    J Clin Psychiatry; 1994 Jun 15; 55(6):234-41. PubMed ID: 8071277
    [Abstract] [Full Text] [Related]

  • 12. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ.
    J Clin Psychiatry; 1997 May 15; 58(5):185-92. PubMed ID: 9184611
    [Abstract] [Full Text] [Related]

  • 13. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Ciraulo DA, Knapp C, Rotrosen J, Sarid-Segal O, Ciraulo AM, LoCastro J, Greenblatt DJ, Leiderman D.
    Addiction; 2005 Mar 15; 100 Suppl 1():23-31. PubMed ID: 15730347
    [Abstract] [Full Text] [Related]

  • 14. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.
    J Clin Psychiatry; 1999 Apr 15; 60(4):226-31. PubMed ID: 10221282
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB.
    J Clin Psychiatry; 2002 May 15; 63(5):434-41. PubMed ID: 12025827
    [Abstract] [Full Text] [Related]

  • 16. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB.
    Arch Gen Psychiatry; 2005 May 15; 62(5):513-20. PubMed ID: 15867104
    [Abstract] [Full Text] [Related]

  • 17. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.
    J Clin Psychiatry; 2001 Jan 15; 62(1):24-9. PubMed ID: 11235924
    [Abstract] [Full Text] [Related]

  • 18. Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
    Sánchez-Lacay JA, Lewis-Fernández R, Goetz D, Blanco C, Salmán E, Davies S, Liebowitz M.
    Depress Anxiety; 2001 Jan 15; 13(3):118-24. PubMed ID: 11387731
    [Abstract] [Full Text] [Related]

  • 19. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
    Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J.
    N Engl J Med; 2000 May 18; 342(20):1462-70. PubMed ID: 10816183
    [Abstract] [Full Text] [Related]

  • 20. A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Mischoulon D, Opitz G, Kelly K, Fava M, Rosenbaum JF.
    Depress Anxiety; 2004 May 18; 19(1):43-50. PubMed ID: 14978785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.